Bruker reported $2.1B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
ABB USD 26.35B 889M Jun/2026
Agilent USD 4.76B 148M Mar/2026
Ametek USD 3.14B 117.67M Mar/2026
Bio Techne USD 688.05M 50.62M Mar/2026
Bio-Rad Laboratories USD 2.94B 35.9M Mar/2026
Bruker USD 2.1B 108.9M Mar/2026
Charles River Laboratories USD 1.49B 41.76M Mar/2026
Danaher USD 13.38B 554M Jun/2026
Fujikura JPY 657.58B 51.98B Mar/2026
Furukawa JPY 119.99B 20.97B Dec/2025
General Electric Aerospace USD 39.7B 664M Jun/2026
Hitachi JPY 7.84T 26.97B Jun/2026
Illumina USD 2.83B 96M Jun/2026
IQVIA Holdings USD 6.23B 6M Jun/2026
Mettler Toledo International USD 1.35B 15.48M Jun/2026
Mitsubishi Electric JPY 4.17T 138.48B Jun/2026
Mitsubishi Heavy Industries JPY 5.44T 676.09B Mar/2026
Myriad Genetics USD 289M 23.8M Jun/2026
Nikon Corporation JPY 646.5B 10.98B Mar/2026
Olympus JPY 706.31B 53.66B Mar/2026
Repligen USD 1.2B 39.19M Jun/2026
Revvity USD 2.13B 111.43M Mar/2026
Smiths GBP 3.06B 1.12B Jun/2026
Thermo Fisher Scientific USD 23.36B 1.05B Jun/2026
Waters USD 3.72B 1.73B Mar/2026